Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1984 5
1985 6
1986 5
1987 12
1988 12
1989 22
1990 24
1991 34
1992 27
1993 24
1994 11
1995 20
1996 16
1997 11
1998 10
1999 6
2000 14
2001 9
2002 6
2003 11
2004 10
2005 10
2006 13
2007 13
2008 11
2009 9
2010 9
2011 13
2012 18
2013 14
2014 12
2015 7
2016 15
2017 16
2018 12
2019 15
2020 22
2021 23
2022 17
2023 18
2024 15

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

543 results

Results by year

Filters applied: . Clear all
Page 1
Spatial and single-cell transcriptomics decipher the cellular environment containing HLA-G+ cancer cells and SPP1+ macrophages in colorectal cancer.
Ozato Y, Kojima Y, Kobayashi Y, Hisamatsu Y, Toshima T, Yonemura Y, Masuda T, Kagawa K, Goto Y, Utou M, Fukunaga M, Gamachi A, Imamura K, Kuze Y, Zenkoh J, Suzuki A, Niida A, Hirose H, Hayashi S, Koseki J, Oki E, Fukuchi S, Murakami K, Tobo T, Nagayama S, Uemura M, Sakamoto T, Oshima M, Doki Y, Eguchi H, Mori M, Iwasaki T, Oda Y, Shibata T, Suzuki Y, Shimamura T, Mimori K. Ozato Y, et al. Among authors: yonemura y. Cell Rep. 2023 Jan 31;42(1):111929. doi: 10.1016/j.celrep.2022.111929. Epub 2023 Jan 18. Cell Rep. 2023. PMID: 36656712 Free article.
The Role of Hyperthermic Intraperitoneal Chemotherapy in Pseudomyxoma Peritonei After Cytoreductive Surgery.
Kusamura S, Barretta F, Yonemura Y, Sugarbaker PH, Moran BJ, Levine EA, Goere D, Baratti D, Nizri E, Morris DL, Glehen O, Sardi A, Barrios P, Quénet F, Villeneuve L, Gómez-Portilla A, de Hingh I, Ceelen W, Pelz JOW, Piso P, González-Moreno S, Van Der Speeten K, Deraco M; Peritoneal Surface Oncology Group International (PSOGI) and the French National Registry of Rare Peritoneal Surface Malignancies (RENAPE). Kusamura S, et al. Among authors: yonemura y. JAMA Surg. 2021 Mar 1;156(3):e206363. doi: 10.1001/jamasurg.2020.6363. Epub 2021 Mar 10. JAMA Surg. 2021. PMID: 33502455 Free PMC article.
Efficacy and safety of romiplostim in refractory aplastic anaemia: a Phase II/III, multicentre, open-label study.
Jang JH, Tomiyama Y, Miyazaki K, Nagafuji K, Usuki K, Uoshima N, Fujisaki T, Kosugi H, Matsumura I, Sasaki K, Kizaki M, Sawa M, Hidaka M, Kobayashi N, Ichikawa S, Yonemura Y, Enokitani K, Matsuda A, Ozawa K, Mitani K, Lee JW, Nakao S. Jang JH, et al. Among authors: yonemura y. Br J Haematol. 2021 Jan;192(1):190-199. doi: 10.1111/bjh.17190. Epub 2020 Nov 5. Br J Haematol. 2021. PMID: 33152120 Free PMC article. Clinical Trial.
Peritoneal cancer treatment.
Yonemura Y, Canbay E, Endou Y, Ishibashi H, Mizumoto A, Miura M, Li Y, Liu Y, Takeshita K, Ichinose M, Takao N, Hirano M, Sako S, Tsukiyama G. Yonemura Y, et al. Expert Opin Pharmacother. 2014 Apr;15(5):623-36. doi: 10.1517/14656566.2014.879571. Expert Opin Pharmacother. 2014. PMID: 24617975 Review.
Long-term efficacy and safety of romiplostim in refractory aplastic anemia: follow-up of a phase 2/3 study.
Mitani K, Lee JW, Jang JH, Tomiyama Y, Miyazaki K, Nagafuji K, Usuki K, Uoshima N, Fujisaki T, Kosugi H, Matsumura I, Sasaki K, Kizaki M, Sawa M, Hidaka M, Kobayashi N, Ichikawa S, Yonemura Y, Murotani K, Shimizu M, Matsuda A, Ozawa K, Nakao S. Mitani K, et al. Among authors: yonemura y. Blood Adv. 2024 Mar 26;8(6):1415-1419. doi: 10.1182/bloodadvances.2023010959. Blood Adv. 2024. PMID: 38134300 Free PMC article. Clinical Trial. No abstract available.
Spatial and single-cell colocalisation analysis reveals MDK-mediated immunosuppressive environment with regulatory T cells in colorectal carcinogenesis.
Hashimoto M, Kojima Y, Sakamoto T, Ozato Y, Nakano Y, Abe T, Hosoda K, Saito H, Higuchi S, Hisamatsu Y, Toshima T, Yonemura Y, Masuda T, Hata T, Nagayama S, Kagawa K, Goto Y, Utou M, Gamachi A, Imamura K, Kuze Y, Zenkoh J, Suzuki A, Takahashi K, Niida A, Hirose H, Hayashi S, Koseki J, Fukuchi S, Murakami K, Yoshizumi T, Kadomatsu K, Tobo T, Oda Y, Uemura M, Eguchi H, Doki Y, Mori M, Oshima M, Shibata T, Suzuki Y, Shimamura T, Mimori K. Hashimoto M, et al. Among authors: yonemura y. EBioMedicine. 2024 May;103:105102. doi: 10.1016/j.ebiom.2024.105102. Epub 2024 Apr 12. EBioMedicine. 2024. PMID: 38614865 Free PMC article.
Evolution of management in peritoneal surface malignancies.
Canbay E, Torun BC, Torun ES, Yonemura Y. Canbay E, et al. Among authors: yonemura y. Ulus Cerrahi Derg. 2015 Sep 1;32(3):203-7. doi: 10.5152/UCD.2016.3375. eCollection 2016. Ulus Cerrahi Derg. 2015. PMID: 27528813 Free PMC article. Review.
Rationale of Treatment for Peritoneal Metastasis.
Yonemura Y, Ishibashi H, Mizumoto A, Fujita T, Liu Y, Wakama S, Sako S, Takao N, Kitai T, Katayama K, Kamada Y, Taniguchi K, Fujimoto D. Yonemura Y, et al. Gan To Kagaku Ryoho. 2022 Dec;49(13):1723-1726. Gan To Kagaku Ryoho. 2022. PMID: 36732979
Peritoneal metastases.
Yonemura Y, Li Y, Sugarbaker PH, Piso P. Yonemura Y, et al. Gastroenterol Res Pract. 2012;2012:695351. doi: 10.1155/2012/695351. Epub 2012 Sep 12. Gastroenterol Res Pract. 2012. PMID: 23008700 Free PMC article. No abstract available.
543 results